There remains a substantial gap throughout Europe between the need and desire for HIV pre-exposure prophylaxis (PrEP) and the number of people actually using it, an online workshop convened towards the end of last year by the European AIDS Clinical Society (EACS) heard. The workshop on PrEP was the second part of its fourth Standard… Read More »
Acetaminophen, known by the brand names Tylenol and Panadol, is the most widely used drug ingredient in the U.S., taken by more than 50 million Americans every week.1 Most don’t think twice about popping a couple of Tylenol tablets to take the edge off a headache or other minor aches and pains, believing it to… Read More »
A US study has concluded that weight gain is greater by around 2 to 4 kg in HIV-positive people taking bictegravir or dolutegravir as part of their first antiretroviral therapy (ART), compared to their counterparts using other drug regimens. A similar effect was reported in those using the protease inhibitor darunavir. The study led by… Read More »
A Canadian study aimed at researching the attitudes of mothers living with HIV has found that more support and education is needed around the recommendation to bottle feed their infants. This is particularly true for women who have moved to wealthy countries from low-income countries, where infant care is completely different and women are told… Read More »